Erythro 250 Tablet contains Erythromycin 250 mg, a macrolide antibiotic effective against a broad spectrum of bacterial infections. It functions by inhibiting bacterial protein synthesis through binding to the 50S ribosomal subunit, thereby preventing bacterial growth and replication. Erythro 250 is indicated for the treatment of respiratory tract infections, skin and soft tissue infections, otitis media, and certain sexually transmitted infections caused by susceptible strains of bacteria. It is also utilized in patients allergic to penicillin as an alternative therapy. The tablet should be administered orally, preferably on an empty stomach to enhance absorption, with a dosage regimen tailored according to the severity and type of infection, as well as patient-specific factors. Common adverse effects include gastrointestinal disturbances such as nausea, vomiting, abdominal pain, and diarrhea. Hypersensitivity reactions, including rash and anaphylaxis, are rare but require immediate medical attention. Caution is advised in patients with hepatic impairment or a history of cardiac arrhythmias, as erythromycin may prolong the QT interval. Drug interactions may occur with agents metabolized by the cytochrome P450 system. Erythro 250 Tablet should be used under medical supervision, ensuring adherence to prescribed dosage and duration to prevent resistance development.